Oruka Therapeutics, Inc. Marketable Securities, Current in USD from Q4 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Oruka Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2024 to Q3 2025.
  • Oruka Therapeutics, Inc. Marketable Securities, Current for the quarter ending September 30, 2025 was $258M.
Marketable Securities, Current, Quarterly (USD)

Oruka Therapeutics, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $258M Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $263M Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $266M Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $314M Dec 31, 2024 10-Q 2025-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.